Adagio Medical Holdings, INC. 8-K Filing
Ticker: ADGM · Form: 8-K · Filed: Mar 27, 2026 · CIK: 0002006986
| Field | Detail |
|---|---|
| Company | Adagio Medical Holdings, INC. (ADGM) |
| Form Type | 8-K |
| Filed Date | Mar 27, 2026 |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 8-K filing submitted by Adagio Medical Holdings, INC. (ticker: ADGM) to the SEC on Mar 27, 2026.
What are the key financial figures in this filing?
Key dollar amounts include: $0.0001 (ch registered Common Stock, par value $0.0001 per share ADGM The Nasdaq Stock Mar).
How long is this filing?
Adagio Medical Holdings, INC.'s 8-K filing is 2 pages with approximately 525 words. Estimated reading time is 2 minutes.
Where can I view the full 8-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 525 words · 2 min read · ~2 pages · Grade level 10.7 · Accepted 2026-03-27 08:00:29
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share ADGM The Nasdaq Stock Mar
Filing Documents
- adgm-20260326x8k.htm (8-K) — 36KB
- adgm-20260326xex99d1.htm (EX-99.1) — 150KB
- 0001104659-26-035699.txt ( ) — 320KB
- adgm-20260326.xsd (EX-101.SCH) — 3KB
- adgm-20260326_def.xml (EX-101.DEF) — 3KB
- adgm-20260326_lab.xml (EX-101.LAB) — 17KB
- adgm-20260326_pre.xml (EX-101.PRE) — 12KB
- adgm-20260326x8k_htm.xml (XML) — 5KB
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition. On March 26, 2026, Adagio Medical Holdings, Inc. (the "Company"), issued a press release announcing the Company's financial results for the fourth quarter and fiscal year ended December 31, 2025, and providing a business update. A copy of this press release is furnished as Exhibit 99.1 and is incorporated herein by reference. The information furnished with this Item 2.02, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any other filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release, dated March 26, 2026 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: March 26, 2026 Adagio Medical Holdings, Inc. By: /s/ Deborah Kaster Name: Deborah Kaster Title: Chief Financial Officer and Chief Business Officer 3